Consensus of recommendations guiding comparative effectiveness research methods-Reference-Cited by-同舟云学术

Consensus of recommendations guiding comparative effectiveness research methods

Published:2016-06-30 Issue:12 Volume:25 Page:1354-1360
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Morton Jacob B.¹²,McConeghy Robert¹,Heinrich Kirstin³,Gatto Nicolle M.⁴⁵,Caffrey Aisling R.¹²⁶

Affiliation:

1. University of Rhode Island; Department of Pharmacy Practice, College of Pharmacy; Kingston RI USA

2. Veterans Affairs Medical Center; Infectious Diseases Research Program and Center of Innovation in Long Term Services and Supports; Providence RI USA

3. Pfizer Inc.; Collegeville PA USA

4. Pfizer Inc.; New York NY USA

5. Columbia University; Mailman School of Public Health; New York NY USA

6. Brown University School of Public Health; Providence RI USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference29 articles.

1. PCORI (Patient-Centered Outcomes Research Institute) Methodology Committee 2013 http://www.pcori.org/assets/2013/11/PCORI-Methodology-Report.pdf

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methodology and reporting guidelines;Pragmatic Randomized Clinical Trials;2021

2. Comparative Effectiveness Research;Pharmacoepidemiology;2019-10-18

3. Considerations in characterizing real‐world data relevance and quality for regulatory purposes: A commentary;Pharmacoepidemiology and Drug Safety;2018-12-05

4. Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG);Clinical Pharmacology & Therapeutics;2018-05-07

5. Comparative effectiveness of 8- and 12-week ledipasvir/sofosbuvir regimens for HCV infection;Antiviral Therapy;2018